Vitamin C Co. Pushes To Ax $153M Antitrust Award

Law360, New York (June 3, 2013, 8:34 PM EDT) -- North China Pharmaceutical Group Corp. urged a New York federal court Friday to toss a $153 million damages award against the company because the recent vitamin C price-fixing trial improperly passed judgment on the Chinese government's export policies.

The company told the court in a reply brief Friday that the act of state doctrine was designed to block exactly the kind of case the plaintiffs have made at trial and in their more recent briefs by protecting foreign governments' conduct from being put at issue in...
To view the full article, register now.